DaVita Inc. (NYSE:DVA) Shares Sold by Mount Lucas Management LP

Mount Lucas Management LP decreased its position in shares of DaVita Inc. (NYSE:DVA) by 5.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,810 shares of the company’s stock after selling 801 shares during the quarter. DaVita comprises about 0.7% of Mount Lucas Management LP’s investment portfolio, making the stock its 29th largest holding. Mount Lucas Management LP’s holdings in DaVita were worth $1,916,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. MML Investors Services LLC boosted its stake in DaVita by 1.3% during the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after purchasing an additional 68 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock worth $133,000 after buying an additional 68 shares during the period. Impact Partnership Wealth LLC grew its holdings in DaVita by 3.7% in the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock worth $290,000 after buying an additional 70 shares in the last quarter. Contravisory Investment Management Inc. increased its position in DaVita by 1.2% in the 4th quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after acquiring an additional 73 shares during the period. Finally, Nilsine Partners LLC raised its stake in DaVita by 0.8% during the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company’s stock valued at $1,669,000 after acquiring an additional 92 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

NYSE:DVA opened at $146.73 on Monday. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The firm has a market cap of $11.74 billion, a P/E ratio of 13.66, a PEG ratio of 1.07 and a beta of 0.99. The business’s 50-day moving average price is $159.43 and its 200 day moving average price is $157.95. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Barclays increased their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research report on Friday, February 21st. Finally, Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.